Interphase cytogenetics by in situ hybridization (ISH) using a panel of centromere-associated DNA probes for chromosomes 1, 7, 9, 10,11,16,17, and 18 was performed on 5 /mi thick frozen tissue sections of transitional cell carcinomas (TCCs) of the urinary bladder. By this approach, chromosome ploidy, numerical chromosome aberrations, imbalance between chromosomes, and heterogeneity of aberrations within individual tumours were determined. In 15 of 24 TCCs, loss or underrepresentation of chromosome 9, compared with the ISH copy numbers of at least five other chromosomes, was demonstrated. Independently, RFLP analysis were performed on the same cases to detect loss of heterozygosity (LOH) of chromosome loci 9q34, llp lS , 16q22-24,17pl3, and 18q21. LOH was found in 9 of 19 informative cases for chromosome locus 9q34. Comparison of the ISH and RFLP results showed no correlation between numerical aberration and LOH for the loci on chromosomes 11,16,17, and 18. However, numerical loss of chromosome 9 was found in 89 per cent (eight of nine cases) with LOH for 9q34. Conversely, LOH at 9q34 was observed in only 67 per cent (eight of 12 cases) with underrepresentation of chromosome 9. Moreover, in 60 per cent of the non-informative cases (three of five cases), underrepresentation for chromosome 9 was observed. These results indicate that the heterochromatin probe for chromosome 9 can be reliably used in TCC tissue sections for the detection of chromosomal loss. In aneuploid TCCs, this DNA probe can be used for the detection of chromosomal underrepresentation only in combination with other centromere-associated DNA probes. on 9q, lip, 16q, 17p, and 18q is involved in various human cancers, including urinary bladder cancers.13"18 The RFLP probe for 9q (9q34 locus), in particular, has been shown to be indicative for changes in chromosome 9 in bladder cancer. The existence o f two allelic loci has been postulated, one in each o f both chromosomal arms.19 Recently, the deleted regions on chromosome 9 in bladder cancer were better defined.20 It has been suggested that 9p LOH may be associated with a more aggressive biological behaviour or early disease progression.20
INTRODUCTION
Dénaturation of probe and target D N A was performed simultaneously by heating the slides in a moist chamber to 70°C for 3 min. After hybridization for 2-16 h at 37°C, the coverslips were removed by immersing the slides in 2 x SSC, pH 7-0 at 42°C. Post-hybridization washing steps were performed twice in 60 per cent formamide-2 x SSC, pH 7*0 for 5 min and twice in 2 x SSC, pH 7*0 for 5 min at 42°C.
Immunocytochemical detection o f the hybridized DNA probes was performed as previously described24,25 with mouse anti-biotin (DAKO A/S, Glostrup, Denmark), biotin-labelled horse anti-mouse IgG (Vector, Burlingame, CA, U.S.A.), and a final incuba tion with the avidin-biotin-labelled peroxidase complex (Vectastain Elite ABC Kit, Vector). All immuno cytochemical steps were performed for 30 min at 37°C. The D N A probe was visualized with 0*5 mg/ml 3,3'diaminobenzidine tetrahydrochloride (DAB, Sigma), 0*65 per cent imidazole (Marck, Darmstadt, Germany), 0*015 per cent H20 2 (Merck) in PBS for 3 min at pH 7*8, and the signal was amplified with C uS04 (0-5 per cent in 0*9 per cent NaCl) for 3 min. The slides were counterstained with haematoxylin and mounted in Permount (Fisher Scientific, New Jersey, U.S.A.).
Evaluation o f ISH results
The reproducibility and validity of a protocol to detect and evaluate chromosome copy numbers by ISH in 5/im routinely processed tissue sections have been described elsewhere. 25 A disadvantage of the use o f tissue sections is that due to truncation of a significant number of nuclei, the number o f ISH signals per nucleus will be under estimated compared with the actual copy number o f the target chromosome.25"28 Therefore, we evaluated sepa rately within each section the tumour area, normal tissue, and stromal cells, since no simple correction factors for truncation of nuclei are available so far. In diploid tumours, the true chromosome copy number is detectable in about 50 per cent of the nuclei, so that monosomy or trisomy can be determined conclusively. However, with increasing nuclear size, the true chromo some copy number will be increasingly underestimated. For this reason, hybridization with different DNA probes on the same tumour areas in parallel sections is necessary to study the imbalance of chromosome copy numbers and, as a result, the specific loss of chromosomes. 4 The Kolmogorov-Smirnov test was used, Under representation of a specific chromosome was seen as a shift to the left of the ISH signal distribution when compared with non-aberrant probe distributions. Con versely, gain of a specific chromosome was seen as a shift to the left. P values of 0-001 or less were considered significant.
Statistical methods

DNA isolation and Southern blot analysis
RFLP analysis was performed as described previ ously.40 Briefly, high molecular weight DNA (about Table I-A summary of the RFLP and ISH results for the 24 transitional cell carcinomas. For ISH, the  centromere-associated D N A probes for chromosomes 1 , 7, 9, 10, 11, 16, 17 Table I summarizes the RFLP and ISH results for each of the 24 TCCs. These were ranged according to their chromosome ploidy as determined on basis of ISH. Cases 1-13 were classified as chromosome diploid and cases 14-24 as aneuploid, of which cases 22-24 were also heterogeneous, i.e., mixed diploid and aneuploid.
RESULTS
Evaluation of the ISH reactions showed in 18 patients 27 times a loss or gain of ISH signals compared with the mean chromosome ploidy. A numerical loss of chromo some 9 was found in 15 cases (62-5 per cent). In 13 patients, we found 24 times LOH for one or more markers. The most frequent allelic loss was seen for the marker on chromosome 9q. Of 19 informative cases (79 per cent), we found LOH of the 9q34 locus in nine tumours (47 per cent).
Chromosome diploid tumours ( cases 1-13)
Numerical chromosome aberrations were detected in 10 ont of 13 diploid TCCs (Table I) . In eight cases, a loss of chromosome 9 was observed. In two cases, an ad ditional loss of chromosome 17 was detected. One case (case 4) demonstrated a loss of chromosome 10, whereas case 6 showed loss of chromosome 18, next to a loss of chromosome 9. Loss of chromosome 18 was also observed in case 9. Figure 1A shows the quantitative evaluation of the hybridization signals of case 1 for the centromere-associated D N A probes for chromosomes 1, 
Chromosome aneuploid tumours (cases 14-24)
In 5 of 11 aneuploid cases, underrepresentation of chromosome 9, compared with the other chromosomes, was detected. In two cases (cases 15 and 16), overrepre sentation of chromosome 1 was observed. An additional loss of chromosome 17, next to loss o f chromosome 9, was detected in case 20. Case 19 showed loss o f chromo some 18 as the only numerical aberration. Figure 1C shows the frequency distribution of case 16 by evaluating the ISH signals in 200 nuclei in serial sections, showing a mean between 3-0 and 3-3 for the copy number of chromosomes 7, 11, 16, 17, and 18, and a modal copy number of four ISH signals per nucleus. For chromosome 1 the mean copy number was 3-9, and the modal copy number was five to six ISH signals per nucleus, representing a relative overrepresentation or gain of this chromosome (P values<0*001). The mean and modal copy numbers for chromosome 9 were 2*4 and 2, respectively, demonstrating an underrepresen tation or loss of this chromosome (P values<0-001).
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Southern blots o f tumour and constitutional DNA from cases 16 and 17 are shown in Figures 2G and 2H , hybridized to the 9q and 1 lp probe, respectively. For the 9q probe, case 16 demonstrates LOH, while case 17 is not informative (Fig, 2G) . For the lip probe, case 16 retains the lip allele, whereas case 17 reveals LOH (Fig. 2H) 
.Ê valuation of ISH signals for the three aneuploid heterogeneous cases (cases 22-24) revealed extensive chromosome heterogeneity, both in the range of ISH signals for the eight different D N A probes in the indi vidual tumour cells and between different tumour areas in the same case o f TCC.
We have therefore classified these three cases as heterogeneous. In two cases (cases 22 and 24), loss of the heterochromatin region of chromo some 9 was detected after screening of serial sections with the eight centromere-associated D N A probes. In the tetraploid tumour areas, we observed an ISH copy number of chromosome 9 of maximum two indicated as an apparent loss o f two copies o f chromosome 9 (Table  1 ). Figure 21 
DISCUSSION
Several investigations have demonstrated that centromere-associated D N A probes can be applied in ISH techniques to determine numerical chromosome aberrations in interphase nuclei o f tumours.21-30
Thompson ei aL49 described a method o f hybridization to sections more than 20 jam thick, to overcome difficul ties in the analysis o f gene or chromosome copy number due to truncation of nuclei. Since these analyses have to be performed using laser-scanning confocal microscopy, this approach is not routinely applicable.
Our study shows the application of ISH bservations strongly confirm other published data, where the cytogenetic observations concerning loss of chromosome 9 in low-grade, low-stage TCCs were con firmed by the ISH approach. Moreover, the frequent occurrence of loss of chromosome 9 in early stages of TCC is in agreement with the observation of Tsai et a/.,33 who showed that LOH of markers on chromosome 9q could be detected in 67 per cent of the informative cases. Comparison of the ISH results with RFLP analy sis revealed that numerical loss of chromosome 9 was found in 89 per cent of the cases with LOH for 9q34. However, only 67 per cent o f cases with loss of chromo some 9 as detected by ISH showed LOH for 9q34.
The process of tetraploidization is a generally accepted concept in tumour progression.12 In the aneu ploid TCCs, the apparent loss of two copies of chromo some 9 strongly indicates that the loss of one copy of this chromosome occurred before tetraploidization took place. This confirms our previous suggestion that loss of chromosome 9 is a primary or early event in carcino genesis of the urinary bladder31 and that it is conserved during the process of tumour progression and invasion. The loss of chromosome 9 as detected by ISH is most probably not limited to a small part of 9q. Because this D N A target is situated in the heterochromatin on 9q, close to the centromere, only a complete loss of this heterochromatin region would result in a complete dis appearance of the chromosome 9 signal. Deletion of either 9q or 9p would preserve part of this target sequence, resulting in positive but less intense or less extended ISH signals. In our RFLP analysis we used one polymorphic marker located at 9q34. This may explain our observation that in four cases (2, 4, 7, and 15) there was an ISH loss of chromosome 9, but no LOH was observed with RFLP analysis. These cases should involve complex chromosomal rearrangements, with loss of the he ter o chromatin region of chromosome 9 and retention of the 9q34 region. Translocation of part o f the 9q-arm could be the most likely explanation.
For the other chromosomes studied, we found no correlation between LOH and centromeric loss. The biological meaning of these observations could be that in those cases where LOH was found but no loss was observed by ISH for that particular chromosome, an interstitial deletion, chromosomal rearrangement, or duplication of a part of that chromosome was involved.
Putative tumour suppressor genes involved in bladder carcinoma are located at the region between 9pl 2-13 and 9q34.20,51,52 The loss o f the putative tumour sup pressor gene on chromosome 9 also comprises, in most cases, the heterochromatin region on 9q. ISH with a centromere 9 probe can therefore be used to monitor this loss in pathological specimens. On the other hand, loss of tumour suppressor genes on chromosomes l ip and 17p, which is frequent in bladder tumours, is not associated with the loss of any entire chromosome or with partial loss including the centromere. Screening for loss of these tumour suppressor genes by ISH should be done using specific cosmid probes located near the relevant locus. In this respect, the strategies of Matsumura et al. 53 demonstrated that LOH of 17p in breast tumours correlated with loss of ISH signals of a 17p cosmid probe. N o correlation was found with the centromeric probe. Similarly in our studies on bladder tumours, no correlation was found with the copy number for the centromeric probe. ISH analysis using tissue sections is a more specific approach than RFLP to karyotyping, since it is possible to evaluate results at the individual cell level, while Southern blot analysis provides a quantitative but in tegral overview of changes that dominate within the tumour. In our study, in three aneuploid cases in which LOH for the chromosome 9 locus was found, we detected a DNA diploid tumour area next to the D N A aneuploid area. An ISH approach can discriminate between these. Tissue microdissection and subsequent PCR-RFLP analysis will allow the examination of LOH o f specific chromosomal regions.54,55 Different clones that might exist among neoplastic cells can then be determined and studied in greater detail.
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